Literature DB >> 25163907

Cilengitide in glioblastoma: when did it fail?

Olivier L Chinot1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25163907     DOI： 10.1016/S1470-2045(14)70403-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  10 in total

1.  Inter-heterogeneity and intra-heterogeneity of αvβ3 in non-small cell lung cancer and small cell lung cancer patients as revealed by 68Ga-RGD2 PET imaging.

Authors:  Fei Kang; Zhe Wang; Guoquan Li; Shengjun Wang; Daliang Liu; Mingru Zhang; Mingxuan Zhao; Weidong Yang; Jing Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-12       Impact factor: 9.236

2.  Inhibition of angiogenesis and tumor progression of MK-0429, an integrin αvβ3 antagonist, on oral squamous cell carcinoma.

Authors:  Takayuki Nakagawa; Kouji Ohta; Takako Naruse; Miyuki Sakuma; Syohei Fukada; Nao Yamakado; Misaki Akagi; Kazuki Sasaki; Chieko Niwata; Shigehiro Ono; Tomonao Aikawa
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-17       Impact factor: 4.322

Review 3.  Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?

Authors:  William Echavidre; Vincent Picco; Marc Faraggi; Christopher Montemagno
Journal:  Pharmaceutics       Date:  2022-05-13       Impact factor: 6.525

Review 4.  Integrin-based therapeutics: biological basis, clinical use and new drugs.

Authors:  Klaus Ley; Jesus Rivera-Nieves; William J Sandborn; Sanford Shattil
Journal:  Nat Rev Drug Discov       Date:  2016-01-29       Impact factor: 84.694

Review 5.  Integrins and Exosomes, a Dangerous Liaison in Cancer Progression.

Authors:  Mayra Paolillo; Sergio Schinelli
Journal:  Cancers (Basel)       Date:  2017-07-26       Impact factor: 6.639

6.  Urokinase-derived peptide UP-7 suppresses tumor angiogenesis and metastasis through inhibition of FAK activation.

Authors:  Hyun-Kyung Kim; Purevjargal Naidansuren; Seung Woo Lee; Rae-Kwon Kim; Su-Jae Lee; Suk Keun Lee; Yong-Kil Hong; Young Ae Joe
Journal:  Oncotarget       Date:  2018-01-10

7.  Recombinant RGD-disintegrin DisBa-01 blocks integrin αvβ3 and impairs VEGF signaling in endothelial cells.

Authors:  Taís M Danilucci; Patty K Santos; Bianca C Pachane; Graziéle F D Pisani; Rafael L B Lino; Bruna C Casali; Wanessa F Altei; Heloisa S Selistre-de-Araujo
Journal:  Cell Commun Signal       Date:  2019-03-20       Impact factor: 5.712

8.  The Effects of αvβ3 Integrin Blockage in Breast Tumor and Endothelial Cells under Hypoxia In Vitro.

Authors:  Bruna C Casali; Larissa T Gozzer; Matheus P Baptista; Wanessa F Altei; Heloisa S Selistre-de-Araújo
Journal:  Int J Mol Sci       Date:  2022-02-03       Impact factor: 5.923

9.  Integrin β3 Promotes Resistance to EGFR-TKI in Non-Small-Cell Lung Cancer by Upregulating AXL through the YAP Pathway.

Authors:  Qi Sun; Zhihua Lu; Yanpeng Zhang; Dong Xue; Huayu Xia; Junjun She; Fanni Li
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

Review 10.  Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging.

Authors:  Deling Li; Chirag B Patel; Guofan Xu; Andrei Iagaru; Zhaohui Zhu; Liwei Zhang; Zhen Cheng
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.